113 related articles for article (PubMed ID: 27070693)
1. Blood-Brain Barrier Breakdown Determines Differential Therapeutic Outcome in Genetically Diverse Forms of Medulloblastoma.
Guerit S; Liebner S
Cancer Cell; 2016 Apr; 29(4):427-429. PubMed ID: 27070693
[TBL] [Abstract][Full Text] [Related]
2. Foretinib is effective therapy for metastatic sonic hedgehog medulloblastoma.
Faria CC; Golbourn BJ; Dubuc AM; Remke M; Diaz RJ; Agnihotri S; Luck A; Sabha N; Olsen S; Wu X; Garzia L; Ramaswamy V; Mack SC; Wang X; Leadley M; Reynaud D; Ermini L; Post M; Northcott PA; Pfister SM; Croul SE; Kool M; Korshunov A; Smith CA; Taylor MD; Rutka JT
Cancer Res; 2015 Jan; 75(1):134-46. PubMed ID: 25391241
[TBL] [Abstract][Full Text] [Related]
3. SHH inhibitors for the treatment of medulloblastoma.
Samkari A; White J; Packer R
Expert Rev Neurother; 2015; 15(7):763-70. PubMed ID: 26027634
[TBL] [Abstract][Full Text] [Related]
4. Wnt/β-catenin signaling inhibits the Shh pathway and impairs tumor growth in Shh-dependent medulloblastoma.
Pöschl J; Bartels M; Ohli J; Bianchi E; Kuteykin-Teplyakov K; Grammel D; Ahlfeld J; Schüller U
Acta Neuropathol; 2014 Apr; 127(4):605-7. PubMed ID: 24531885
[No Abstract] [Full Text] [Related]
5. Glabrescione B delivery by self-assembling micelles efficiently inhibits tumor growth in preclinical models of Hedgehog-dependent medulloblastoma.
Infante P; Malfanti A; Quaglio D; Balducci S; De Martin S; Bufalieri F; Mastrotto F; Basili I; Garofalo M; Lospinoso Severini L; Mori M; Manni I; Moretti M; Nicoletti C; Piaggio G; Caliceti P; Botta B; Ghirga F; Salmaso S; Di Marcotullio L
Cancer Lett; 2021 Feb; 499():220-231. PubMed ID: 33249196
[TBL] [Abstract][Full Text] [Related]
6. Could an endoneurial endothelial crosstalk between Wnt/β-catenin and Sonic Hedgehog pathways underlie the early disruption of the infra-orbital blood-nerve barrier following chronic constriction injury?
Moreau N; Mauborgne A; Couraud PO; Romero IA; Weksler BB; Villanueva L; Pohl M; Boucher Y
Mol Pain; 2017; 13():1744806917727625. PubMed ID: 28814148
[TBL] [Abstract][Full Text] [Related]
7. β-Catenin-Gli1 interaction regulates proliferation and tumor growth in medulloblastoma.
Zinke J; Schneider FT; Harter PN; Thom S; Ziegler N; Toftgård R; Plate KH; Liebner S
Mol Cancer; 2015 Feb; 14(1):17. PubMed ID: 25645196
[TBL] [Abstract][Full Text] [Related]
8. PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma.
Singh AR; Joshi S; Zulcic M; Alcaraz M; Garlich JR; Morales GA; Cho YJ; Bao L; Levy ML; Newbury R; Malicki D; Messer K; Crawford J; Durden DL
PLoS One; 2016; 11(3):e0150836. PubMed ID: 26938241
[TBL] [Abstract][Full Text] [Related]
9. PTEN loss mitigates the response of medulloblastoma to Hedgehog pathway inhibition.
Metcalfe C; Alicke B; Crow A; Lamoureux M; Dijkgraaf GJ; Peale F; Gould SE; de Sauvage FJ
Cancer Res; 2013 Dec; 73(23):7034-42. PubMed ID: 24154871
[TBL] [Abstract][Full Text] [Related]
10. Medulloblastoma: signalling a change in treatment.
Gilbertson RJ
Lancet Oncol; 2004 Apr; 5(4):209-18. PubMed ID: 15050952
[TBL] [Abstract][Full Text] [Related]
11. Engineered biomimetic nanoparticle for dual targeting of the cancer stem-like cell population in sonic hedgehog medulloblastoma.
Kim J; Dey A; Malhotra A; Liu J; Ahn SI; Sei YJ; Kenney AM; MacDonald TJ; Kim Y
Proc Natl Acad Sci U S A; 2020 Sep; 117(39):24205-24212. PubMed ID: 32934143
[TBL] [Abstract][Full Text] [Related]
12. HDAC inhibitors to the rescue in sonic hedgehog medulloblastoma.
Becher OJ
Neuro Oncol; 2019 Sep; 21(9):1091-1092. PubMed ID: 31242287
[No Abstract] [Full Text] [Related]
13. Inhibition of SHH pathway mechanisms by arsenic trioxide in pediatric medulloblastomas: a comprehensive literature review.
Klinger PH; Andrade AF; Delsin LE; Queiroz RG; Scrideli CA; Tone LG; Valera ET
Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28218785
[TBL] [Abstract][Full Text] [Related]
14. Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype.
Phoenix TN; Patmore DM; Boop S; Boulos N; Jacus MO; Patel YT; Roussel MF; Finkelstein D; Goumnerova L; Perreault S; Wadhwa E; Cho YJ; Stewart CF; Gilbertson RJ
Cancer Cell; 2016 Apr; 29(4):508-522. PubMed ID: 27050100
[TBL] [Abstract][Full Text] [Related]
15. Curcumin suppresses cell proliferation through inhibition of the Wnt/β-catenin signaling pathway in medulloblastoma.
He M; Li Y; Zhang L; Li L; Shen Y; Lin L; Zheng W; Chen L; Bian X; Ng HK; Tang L
Oncol Rep; 2014 Jul; 32(1):173-80. PubMed ID: 24858998
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of WNT signaling attenuates self-renewal of SHH-subgroup medulloblastoma.
Rodriguez-Blanco J; Pednekar L; Penas C; Li B; Martin V; Long J; Lee E; Weiss WA; Rodriguez C; Mehrdad N; Nguyen DM; Ayad NG; Rai P; Capobianco AJ; Robbins DJ
Oncogene; 2017 Nov; 36(45):6306-6314. PubMed ID: 28714964
[TBL] [Abstract][Full Text] [Related]
17. Medulloblastoma growth inhibition by hedgehog pathway blockade.
Berman DM; Karhadkar SS; Hallahan AR; Pritchard JI; Eberhart CG; Watkins DN; Chen JK; Cooper MK; Taipale J; Olson JM; Beachy PA
Science; 2002 Aug; 297(5586):1559-61. PubMed ID: 12202832
[TBL] [Abstract][Full Text] [Related]
18. Failure of a medulloblastoma-derived mutant of SUFU to suppress WNT signaling.
Taylor MD; Zhang X; Liu L; Hui CC; Mainprize TG; Scherer SW; Wainwright B; Hogg D; Rutka JT
Oncogene; 2004 Jun; 23(26):4577-83. PubMed ID: 15077159
[TBL] [Abstract][Full Text] [Related]
19. Targeted therapy done right: Direct sonic hedgehog inhibition for sonic hedgehog medulloblastoma.
Nellan A; Jackson S
Neuro Oncol; 2024 Apr; 26(4):623-624. PubMed ID: 38290484
[No Abstract] [Full Text] [Related]
20. Challenges and Recent Advances of Novel Chemical Inhibitors in Medulloblastoma Therapy.
Maurya A; Patel UK; Yadav JK; Singh VP; Agarwal A
Methods Mol Biol; 2022; 2423():123-140. PubMed ID: 34978695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
